We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$595M
AUM Growth
-$61.1M
Cap. Flow
-$55.7M
Cap. Flow %
-9.37%
Top 10 Hldgs %
57.86%
Holding
38
New
10
Increased
10
Reduced
16
Closed
2

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$32.4M
2
AGN
Allergan plc
AGN
+$11.2M
3
CI icon
Cigna
CI
+$7.92M
4
BSX icon
Boston Scientific
BSX
+$6.4M
5
SRCL
Stericycle Inc
SRCL
+$5.55M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$48.2M
2
BAX icon
Baxter International
BAX
+$15.4M
3
SHPG
Shire pic
SHPG
+$14.1M
4
ELV icon
Elevance Health
ELV
+$13.1M
5
ABT icon
Abbott
ABT
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 97.59%
2 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
1
Abbott
ABT
$175B
$61.6M 10.36%
1,079,842
-191,900
-15% -$10.6M
BAX icon
2
Baxter International
BAX
$11.7B
$44.9M 7.55%
694,438
-239,695
-26% -$15.4M
BSX icon
3
Boston Scientific
BSX
$65.4B
$42.2M 7.09%
1,700,880
+232,000
+16% +$6.4M
RVTY icon
4
Revvity
RVTY
$12.3B
$32.2M 5.42%
440,808
-100,800
-19% -$7.23M
MRK icon
5
Merck
MRK
$315B
$31.4M 5.28%
+585,308
New +$32.4M
AZN icon
6
AstraZeneca
AZN
$262B
$31.1M 5.23%
448,386
+78,050
+21% +$5.26M
ELV icon
7
Elevance Health
ELV
$80.9B
$27.3M 4.59%
121,310
-61,300
-34% -$13.1M
GILD icon
8
Gilead Sciences
GILD
$167B
$25.6M 4.31%
357,890
+22,200
+7% +$1.69M
IART icon
9
Integra LifeSciences
IART
$1.5B
$24.2M 4.08%
506,630
-22,600
-4% -$1.11M
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$23.6M 3.97%
385,006
-74,600
-16% -$4.67M
BIO icon
11
Bio-Rad Laboratories Class A
BIO
$8.15B
$22.7M 3.81%
95,040
-14,400
-13% -$3.49M
PRGO icon
12
Perrigo
PRGO
$1.48B
$21.8M 3.66%
249,540
-29,900
-11% -$2.57M
BIIB icon
13
Biogen
BIIB
$30.4B
$21M 3.52%
65,800
-18,200
-22% -$5.84M
IRWD icon
14
Ironwood Pharmaceuticals
IRWD
$635M
$17.8M 2.99%
1,419,132
-759,920
-35% -$9.93M
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
$15.2M 2.56%
260,200
+77,200
+42% +$4.38M
CI icon
16
Cigna
CI
$74.5B
$14.9M 2.5%
73,170
+39,800
+119% +$7.92M
LLY icon
17
Eli Lilly
LLY
$1.05T
$13M 2.18%
153,414
-566,132
-79% -$48.2M
LH icon
18
Labcorp
LH
$23.2B
$12.8M 2.14%
93,120
+11,640
+14% +$1.54M
PDCO
19
DELISTED
Patterson Companies, Inc.
PDCO
$11M 1.84%
303,132
-93,200
-24% -$3.4M
MCK icon
20
McKesson
MCK
$98.5B
$10.5M 1.76%
67,315
-51,785
-43% -$7.67M
SHPG
21
DELISTED
Shire pic
SHPG
$10.4M 1.75%
67,075
-95,081
-59% -$14.1M
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
$10.3M 1.73%
150,992
+2,900
+2% +$203K
AGN
23
DELISTED
Allergan plc
AGN
$10.2M 1.72%
+62,600
New +$11.2M
GSK icon
24
GSK
GSK
$104B
$9.69M 1.63%
218,650
+109,326
+100% +$5.05M
LXRX icon
25
Lexicon Pharmaceuticals
LXRX
$1.06B
$8.27M 1.39%
837,192
+99,739
+14% +$1.04M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2017 Portfolio in Review

As of Q4 2017, Sector Gamma AS held 38 positions worth $595M, down 9.3% from $656M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sector Gamma AS withdrew a net $55.7M in Q4 2017, closing 2 positions and reducing 16 holdings. Its most notable exit was Impax Laboratories, Inc., an estimated $8.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 98% a quarter earlier, followed by Industrials.

Against the trend, Sector Gamma AS opened a new position in Merck worth $31.4M.

  • Sector Gamma AS's largest Q4 2017 buy was Merck: 585,308 shares worth $31.4M.
  • Sector Gamma AS added most to Cigna in Q4 2017, an estimated $7.92M increase.
  • Sector Gamma AS's biggest Q4 2017 reduction was Eli Lilly, cutting an estimated $48.2M.
  • Sector Gamma AS fully exited Impax Laboratories, Inc. in Q4 2017, selling an estimated $8.57M.
  • Sector Gamma AS's ten largest holdings make up 58% of its $595M portfolio in Q4 2017.
  • Sector Gamma AS opened 10 new positions and closed 2 in Q4 2017.
  • Sector Gamma AS's portfolio value fell 9.3% quarter-over-quarter to $595M.

Based on Sector Gamma AS's 13F filing for Q4 2017, filed 12 Feb 2018.